2005
DOI: 10.1097/00001199-200509000-00006
|View full text |Cite
|
Sign up to set email alerts
|

Neurobehavioral Effects of Amantadine After Pediatric Traumatic Brain Injury

Abstract: After traumatic brain injury, a 12-week course of AMH was safe and, according to parent report, improved behavior. AMH may have the potential to improve cognition in more recently injured children.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
35
1
1

Year Published

2007
2007
2022
2022

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(37 citation statements)
references
References 63 publications
0
35
1
1
Order By: Relevance
“…131,132 Amantadine has been used for post-TBI cognitive and behavioral symptoms, but the results have also been inconsistent. 133,134 Moderate and severe TBI patients are included in some of these studies, highlighting the need for dedicated concussion treatment trials.…”
Section: Medical Managementmentioning
confidence: 99%
“…131,132 Amantadine has been used for post-TBI cognitive and behavioral symptoms, but the results have also been inconsistent. 133,134 Moderate and severe TBI patients are included in some of these studies, highlighting the need for dedicated concussion treatment trials.…”
Section: Medical Managementmentioning
confidence: 99%
“…For example, the BRIEF has been used to assess the effects of medications on executive functions in the everyday life of individuals with attention-deficit hyperactivity disorder (ADHD; Biederman et al, 2011;Dupaul et al, 2012;Findling, Ginsberg, Jain, & Gao, 2009;Maziade et al, 2009;Turgay et al, 2010;Yang et al, 2011), Tourette syndrome (Cummings, Singer, Krieger, Miller, & Mahone, 2002), traumatic brain injury (TBI; Beers, Skold, Dixon, & Adelson, 2005), hepatitis C virus (Rodrigue et al, 2011), major depressive disorder (Roth et al, 2012), and hypertension (Lande et al, 2010). It has also been employed to examine outcomes following interventions such as liver transplantation (Sorensen et al, 2011), chemotherapy in breast cancer (Kesler, Kent, & O'Hara, 2011;McDonald, Conroy, Smith, West, & Saykin, 2013), corticosteroid treatment in children with inflammatory bowel disease (Mrakotsky et al, 2013), and family-based intervention in TBI (Wade, Wolfe, Brown, & Pestian, 2005;Wade, Wolfe, & Pestian, 2004).…”
Section: Intervention Outcomementioning
confidence: 99%
“…However, in the last couple of decades only a handful of medications have been systematically studied. The few drugs that have been studied in experimental or quasi-experimental trials were methylphenidate [1,2], amantadine [3,4], Beers [5] propranolol, Meythaler [6,7] and cholinesterase inhibitors [8,9]. Given the dearth of randomized controlled trials and clinical practice guidelines, medication choices are thus empirical and based on anecdotal experience or on published case reports and series.…”
Section: Background and Purposementioning
confidence: 99%
“…Valproic acid and its derivatives (VPA) (13) Lorazepam (9) Propranolol (8) Carbamazepine (8) Nadolol (6) Risperidone (8) Trazodone (6) Carbamazepine (5) Anger VPA (6) VPA (11) SSRI (5) Carbamazepine (7) Anxiety Buspirone (14) Buspirone (13) Paroxetine (7) Paroxetine (5) Depression Paroxetine (11) Paroxetine (11) Sertraline (10) Methylphenidate (5) Venlafaxine (10) Inattention…”
Section: Agitationmentioning
confidence: 99%